LipiCare Pharmaceuticals develops products based on nano-emulsions of phospholipids to convey fatty medications to the ocular surface effectively and comfortably. LipiCare is now focused on developing the first commercial product based on this technology, Ocular D, a product for treating dryness in the eye with integrated vitamin D. LipiCare has conducted laboratory testing that has shown that the product helps block blue light radiation and thus may provide additional protection to the eye beyond the existing benefits of the nano-emulsion itself. Development of the product is being carried out by subcontractors, chiefly an Italian manufacturer that produces and markets similar products in Europe. Upon receipt of the marketing approval in Europe for LipiCare's Ocular-D product (CE approval through the medical devices track), LipiCare is expected to commence Ocular-D production and marketing. The company is a subsidiary of Biolight.